Chad Messer
Stock Analyst at Lake Street
(0.89)
# 3,957
Out of 5,163 analysts
29
Total ratings
30%
Success rate
-16.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Maintains: Buy | $22 → $32 | $20.36 | +57.17% | 2 | Dec 16, 2025 | |
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.55 | +996.77% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $2.60 | +515.38% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $60.36 | +75.61% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $3.91 | +1,818.16% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $0.98 | +611.38% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $4.53 | +253.20% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $2.40 | +941.67% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $2.44 | +4,572.13% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $114.22 | -56.22% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $60.06 | -20.07% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $41.24 | -27.26% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $6.45 | +349.61% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.39 | +2,490.67% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $71.19 | +20.80% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $15.04 | +192.55% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $16.40 | +912.20% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.46 | +1,132.88% | 1 | May 5, 2020 |
Immunome
Dec 16, 2025
Maintains: Buy
Price Target: $22 → $32
Current: $20.36
Upside: +57.17%
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.55
Upside: +996.77%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $2.60
Upside: +515.38%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $60.36
Upside: +75.61%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $3.91
Upside: +1,818.16%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $0.98
Upside: +611.38%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $4.53
Upside: +253.20%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $2.40
Upside: +941.67%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $2.44
Upside: +4,572.13%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $114.22
Upside: -56.22%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $60.06
Upside: -20.07%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $41.24
Upside: -27.26%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $6.45
Upside: +349.61%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $0.39
Upside: +2,490.67%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $71.19
Upside: +20.80%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $15.04
Upside: +192.55%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $16.40
Upside: +912.20%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.46
Upside: +1,132.88%